Serum parathyroid hormone in relation to all-cause and cardiovascular mortality: The hoorn study

Journal of Clinical Endocrinology and Metabolism

Volumn 98, Issue 4, 2013, Pages

  Van Ballegooijen, A J ^a   Reinders, I ^a   Visser, M ^a,b   Dekker, J M ^b   Nijpels, G ^b   Stehouwer, C D A ^c   Pilz, S ^b,d   Brouwer, I A ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; BRAIN NATRIURETIC PEPTIDE; PARATHYROID HORMONE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUCASIAN; CAUSE OF DEATH; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HEART LEFT VENTRICLE MASS; HUMAN; IMMUNORADIOMETRIC ASSAY; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PARATHYROID HORMONE BLOOD LEVEL; PRIORITY JOURNAL; RISK ASSESSMENT; SURVIVAL; TREND STUDY;

AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; COHORT STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; OSMOLAR CONCENTRATION; PARATHYROID HORMONE; POPULATION;

EID: 84876239071     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2012-4007     Document Type: Article

References (40)

1. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease: a review. Eur Heart J. 2004;25:1776-1787.
2. Garcia de la Torre N, Wass JA, Turner HE. Parathyroid adenomas and cardiovascular risk. Endocr Relat Cancer. 2003;10:309-322.
3. Rostand SG, Drueke TB. Parathyroid hormone, vitamin D, and cardiovascular disease in chronic renal failure. Kidney Int. 1999; 56:383-392.
4. Go AS, Chertow GM, Fan D, McCulloch CE, Hsu CY. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med. 2004;351:1296-1305.
5. Bjorkman M, Sorva A, Tilvis R. Parathyroid hormone asamortality predictor in frail aged inpatients. Gerontology. 2009;55:601-606.
6. Sambrook PN, Chen JS, March LM, et al. Serum parathyroid hormone is associated with increased mortality independent of 25-hydroxyvitamin Dstatus, bone mass, and renal functioninthe frail and very old: a cohort study. J Clin Endocrinol Metab. 2004;89:5477-5481.
7. Chen JS, Sambrook PN, March L, et al. Hypovitaminosis D and parathyroid hormone response in the elderly: effects on bone turnover and mortality. Clin Endocrinol (Oxf). 2008;68:290-298.
8. Premaor MO, Scalco R, da Silva MJ, Furlanetto TW. Secondary hyperparathy roidism is associated with increased risk of hospitalization or death in elderly adults living in a geriatric institution. Gerontology. 2009;55:405-410.
9. Fisher A, Goh S, Srikusalanukul W, Davis M. Elevated serum PTH is independently associated with poor outcomes in older patients with hip fracture and vitamin Dinadequacy. Calcif Tissue Int. 2009; 85:301-309.
10. Jassal SK, Chonchol M, von Muhlen D, Smits G, Barrett-Connor E. Vitamin D, parathyroid hormone, and cardiovascular mortality in older adults: the Rancho Bernardo study. Am J Med. 2010;123: 1114-1120.
11. Kestenbaum B, Katz R, de Boer I, et al. Vitamin D, parathyroid hormone, and cardiovascular events among older adults. J Am Coll Cardiol. 2011;58:1433-1441.
12. Kritchevsky SB, Tooze JA, Neiberg RH, et al; Health ABC Study. 2012 25-Hydroxyvitamin D, parathyroid hormone, and mortality in black and white older adults: the Health ABC Study. J Clin Endocrinol Metab. 2012;97:4156-4165
13. Pilz S, Tomaschitz A, Drechsler C, et al. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J. 2010;31:1591-1598.
14. Schierbeck LL, Jensen TS, Bang U, Jensen G, Kober L, Jensen JE. Parathyroid hormone and vitamin D-markers for cardiovascular and all cause mortality in heart failure. Eur J Heart Fail. 2011;13: 626-632.
15. Cawthon PM, Parimi N, Barrett-Connor E, et al. Serum 25-hydroxyvitamin D, parathyroid hormone, and mortality in older men. J Clin Endocrinol Metab. 2010;95:4625-4634.
16. Hagstrom E, Hellman P, Larsson TE, et al. Plasma parathyroid hormone and the risk of cardiovascular mortality inthe community. Circulation. 2009;119:2765-2771.
17. Anderson JL, Vanwoerkom RC, Horne BD, et al. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: Dependent or independent risk factors? Am Heart J.2011;162:331-339.
18. Hagstrom E, Ingelsson E, Sundstrom J, et al. Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail. 2010;12:1186-1192.
19. Grandi NC, Breitling LP, Hahmann H, et al. Serum parathyroid hormone and risk of adverse outcomes in patients with stable coronary heart disease. Heart. 2011;97:1215-1221.
20. Fraser WD. Hyperparathy roidism. Lancet. 2009;374:145-158.
21. van Ballegooijen AJ, Snijder MB, Visser M, et al. Vitamin D in relation to myocardial structure and function after eight years of follow-up: the Hoorn study. Ann Nutr Metab. 2012;60:69-77.
22. Taylor EN, Curhan GC, Forman JP. Parathyroid hormone and the risk of incident hypertension. J Hypertens. 2008;26:1390-1394.
23. Pirro M, Manfredelli MR, Helou RS, et al. Association of parathyroid hormone and 25-OH-vitamin D levels with arterial stiffness in postmenopausal women with vitamin D insufficiency. J Atheroscler Thromb. 2012;19:924-931.
24. Mooy JM, Grootenhuis PA, de Vries H, et al. Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. The Hoorn Study. Diabetes Care. 1995;18:1270-1273.
25. van Dam RM, Snijder MB, Dekker JM, et al. Potentially modifiable determinants of vitamin D status in an older population in The Netherlands: the Hoorn Study. Am J Clin Nutr. 2007;85:755-761.
26. World Health Organization, International Diabetes Federation. Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia: Report of a WHO/IDF Consultation. Geneva, Switzerland: World Health Organization; 2006.
27. van Ballegooijen AJ, Visser M, Snijder MB, et al. Serum 25-hydroxyvitamin D and parathyroid hormone in relation to plasma B-type natriuretic peptide: the Hoorn Study. Endocr Connect. 2012; 1:48-57.
28. Levey AS, Stevens LA, Schmid CH, et al. A new equation to estimate glomerular filtration rate. Ann Intern Med. 2009;150:604-612.
29. Verkhratsky A. Calcium and cell death. Subcell Biochem. 2007;45: 465-480.
30. Jablonski KL, Chonchol M, Pierce GL, Walker AE, Seals DR. 25-Hydroxyvitamin D deficiency is associated with inflammation-linked vascular endothelial dysfunction in middle-aged and older adults. Hypertension. 2011;57:63-69.
31. Levin GP, Robinson-Cohen C, de Boer IH, et al. Genetic variants and associations of 25-hydroxyvitamin D concentrations with major clinical outcomes. JAMA. 2012;308:1898-1905.
32. Altay H, Zorlu A, Bilgi M, Erol T, Yilmaz MB. Usefulness of parathyroid hormone as a predictor of heart failure with preserved ejection fraction. Biomarkers. 2012;17:447-454.
33. Taylor EN, Rimm EB, Stampfer MJ, Curhan GC. Plasma fibroblast growth factor 23, parathyroid hormone, phosphorus, and risk of coronary heart disease. Am Heart J. 2011;161:956-962.
34. Hawkins NM, Jhund PS, McMurray JJ, Capewell S. Heart failure and socioeconomic status: accumulating evidence of inequality. Eur J Heart Fail. 2012;14:138-146.
35. Heine GH, Nangaku M, Fliser D. Calcium and phosphate impact cardiovascular risk [published online ahead of print October 28, 2012]. Eur Heart J. doi:10.1093/eurheartj/ehs353.
36. Masoro EJ. Dietary restriction-induced life extension: a broadly based biological phenomenon. Biogerontology. 2006;7:153-155.
37. Paik JM, Curhan GC, Taylor EN. Calcium intake and risk of primary hyperparathyroidism in women: prospective cohort study. BMJ. 2012;345:e6390.
38. Ocke MC, Bueno-de-Mesquita HB, Pols MA, Smit HA, van Staveren WA, Kromhout D. The Dutch EPIC food frequency questionnaire. II. Relative validity and reproducibility for nutrients. Int J Epidemiol. 1997;26(Suppl 1):S49-S58.
39. Kerstetter JE, Kenny AM, Insogna KL. Dietary protein and skeletal health: a review of recent human research. Curr Opin Lipidol. 2011; 22:16-20.
40. Tomaschitz A, Ritz E, Pieske B, et al. Aldosterone and parathyroid hormone: a precarious couple for cardiovascular disease. Cardiovasc Res. 2012;94:10-19.